UnitedHealth Group's third-quarter beat strengthened the recovery story, but management's longer-term claim is more demanding. The company reported adjusted earnings of $4.69 per share and revenue of $112.69 billion, then lifted its 2026 adjusted earnings outlook to at least $20.50 per share.
Chief Financial Officer Wayne DeVeydt said the lower end of UnitedHealth's 13% to 16% long-term adjusted earnings growth target was a reasonable starting point for 2027. Applying 13% growth to the new $20.50 floor produces about $23.17 per share. That is a simple scenario, not company guidance for a specific 2027 result.
Where the improvement came from
The medical care ratio, which measures claims costs as a share of premium revenue, improved to 88.4% from 89.9% a year earlier. However, the quarter included $610 million of favorable reserve development from prior periods. That benefit helped the reported improvement and may not repeat at the same scale.
UnitedHealthcare revenue slipped to $86.3 billion from $87.1 billion, while operating earnings rose to $2.8 billion from $1.8 billion. Optum generated $66.9 billion of revenue and $3.7 billion of operating earnings, with Optum Health earnings rebounding to $735 million from $41 million.
Those figures show real operating repair, but they also reveal the trade-off. UnitedHealth is improving profitability while reshaping membership and benefits, so investors need to separate durable pricing and cost control from reserve releases and portfolio actions.
The 2027 test
Management identified share repurchases, value-based care, modernization and AI as potential tailwinds. Medical-cost inflation, reimbursement pressure and Medicaid funding remain risks. The company expects core Medicaid margins to reach a trough in 2026 and return to targeted levels by the end of 2028, which means part of the recovery extends beyond next year.
UnitedHealth's official release set the 2026 adjusted earnings floor at $20.50. The next question is whether 2027 growth can come from recurring operating improvement rather than favorable prior-period items. Medical care ratios, Optum Health profitability, Medicaid margins and membership quality will provide a clearer answer than the stock's rebound alone.